Table 2

Biochemical variables in the various groups at the various time points evaluated in the various groups at the various time points evaluated

SerumPeriod
GroupBaselineShock30T30T60T120
Na (mEq/L)
 Sham145±3.1149±5.9144±4.7154±9.2135±10.50
 Shock-only138±1.2141±5.3140±5.7132±4.3b154±0.00
 Shock+LRS136±2.1132±1.8a131±2.2131±1.2c130±4.70
 Shock+Terli138±2.4134±2.9a138±2.7134±1.5c127±2.90
K (mEq/L)
 Sham4.6±0.34.7±0.24.6±0.25.1±0.34.8±0.10
 Shock-only4.8±0.25.9±0.4a6.4±0.5b6.0±0.97.7±0.00
 Shock+LRS4.2±0.16.4±0.4a4.5±0.2f5.1±0.15.9±0.30
 Shock+Terli4.3±0.15.3±0.2g5.4±0.2d5.4±0.25.6±0.40
Cl (mEq/L)
 Sham108±2.1111±4.6109±4.4115±7.7104±15.5
 Shock-only105±2.4107±4.3106±4.7107±5.2117±0.0
 Shock+LRS100±1.6100±1.794±4.799±1.0a94±4.60
 Shock+Terli104±2.299±2.2102±2.196±3.1b91±3.20
Mg (mg/dL)
 Sham1.9±0.141.7±0.101.7±0.101.7±0.141.8±0.10
 Shock-only1.8±0.082.1±0.082.2±0.11a2.1±0.172.8±0.00
 Shock+LRS1.8±0.102.3±0.131.5±0.08f1.5±0.09d1.7±0.12
 Shock+Terli1.9±0.072.1±0.121.9±0.09h2.1±0.10h2.0±0.22
P (mg/dL)
 Sham9.3±1.009.4±0.919.7±0.749.9±0.9110±2.00
 Shock-only8.8±0.5210.6±0.5912.2±0.91a10.7±1.0013±0.00
 Shock+LRS9.3±0.4812.2±0.858.1±0.42f8.3±0.519.7±0.90
 Shock+Terli8.5±0.4010.1±0.5610.8±0.47d12.0±0.55h11.6±1.8
Urea (mg/dL)
 Sham20.2±2.3321.8±2.3123.1±2.9323.5±2.5617.0±2.00
 Shock-only20.4±2.3325.4±2.4527.4±2.2524.0±0.4531.0±0.00
 Shock+LRS19.1±2.0125.0±2.4321.3±2.0133.6±11.4626.0±4.00
 Shock+Terli26.5±2.7633.0±3.1035.1±3.22a,h37.2±3.2041.1±5.10
UrinePeriod
GroupBaselineShock30T30T60T120
UNaV (mEq/period)
 Sham0.5±0.11.2±0.70.6±0.30.6±0.20.8±0.3
 Shock-only0.7±0.10.6±0.30.2±0.10.2±0.10
 Shock+LRS0.4±0.10.4±0.220.5±4.7c,e2.2±0.80.1±0.0
 Shock+Terli0.5±0.10.2±0.10.2±0.0i0.5±0.30.3±0.1
UKV (mEq/period)
 Sham1.8±0.54.5±1.42.7±0.82.7±0.52.6±1.7
 Shock-only3.7±1.11.5±0.4a0.2±0.10.1±0.0a0
 Shock+LRS1.9±0.31.8±0.3a12.7±5.7c,f2.3±0.6d0.6±0.2
 Shock+Terli2.2±0.31.8±0.8a0.8±0.2h0.9±0.31.5±0.7
UClV (mEq/period)
 Sham2.2±1.24.3±1.71.9±0.51.7±0.31.5±0.8
 Shock-only3.9±0.91.6±0.40.3±0.20.2±0.10
 Shock+LRS1.5±0.31.4±0.419.5±4.9b,e3.7±1.30.4±0.2
 Shock+Terli2.7±0.61.3±0.60.6±0.2i0.6±0.21.1±0.5
UMgV (mg/period)
 Sham3.2±1.31.8±0.41.5±0.91.2±0.40.7±0.5
 Shock-only6.3±1.51.2±0.20.1±0.40.3±0.10
 Shock+LRS3.7±0.72.2±0.69.1±1.6b,f2.2±0.70.4±0.2
 Shock+Terli5.2±0.91.6±0.52.6±1.0i2.0±0.63.3±0.8
UPV (mg/period)
 Sham1.7±1.411.3±6.37.4±3.87.9±3.33.2±1.6
 Shock-only4.3±2.34.7±2.11.2±0.80.2±0.20
 Shock+LRS1.9±1.27.8±2.574.1±20.8b,d14±4.6d3.8±3.0
 Shock+Terli3.3±1.62.4±1.46.1±3.04h7.4±3.314.2±12.2
UureaV (mg/period)
 Sham184.4±49.3371.8±88.1223.8±66.6210.4±43.4162.9±113.1
 Shock-only489.5±82.9117±22.9a18.3±7.915.5±2.2a0
 Shock+LRS203.7±31.1140.9±280.6a468.5±98.8a,e193.4±48.6d64.6±28.2
 Shock+Terli428.3±94.3194.9±77.8103.3±24.4i87.6±27.9282.6±103.6
Uosm (mOsm/kg)
 Sham735.8±96.1748.7±102.3739±85.7734.6±90.6617.5±59.5
 Shock-only563.4±95.7592.6±65.5446.5±154.5a541.3±92.2793±0.0
 Shock+LRS621.0±39.6629.3±37.3368.6±15.5c464.7±27.8b462.8±25.5
 Shock+Terli659.0±46.8693.5±45.9593.4±54.4b522±39.5a653±91.2
  • Values are mean±SE.

  • ap<0.05 vs sham; bp<0.01 vs sham; cp<0.001 vs sham; dp<0.05 vs shock-only; ep<0.01 vs shock-only; fp<0.001 vs shock-only; gp<0.05 vs shock+LRS; hp<0.01 vs shock+LR; ip<0.001 vs shock+LRS.

  • Sham, anesthetized but not subjected to hemorrhagic shock; Shock+LRS, subjected to hemorrhagic shock and subsequently treated with LRS at a volume equal to three times that of the blood removed; Shock+Terli, subjected to hemorrhagic shock and subsequently treated with a 2 mg bolus of terlipressin; Shock30, 30 min after achieving the target MAP (immediately prior to treatment); Shock-only, subjected to hemorrhagic shock and left untreated; T120, 120 min after treatment; T30, 30 min after treatment; T60, 60 min after treatment; UClV, urinary excretion of chloride; UKV, urinary excretion of potassium; UMgV, urinary excretion of magnesium; UNaV, urinary excretion of sodium; Uosm, urine osmolality; UureaV, urinary excretion of urea.